Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

HRS 2020: Boston Scientific’s Next-Gen LAAC Device Hits Targets In PINNACLE FLX Trial

May 14 2020

• By Reed Miller

Minimally invasive transcatheter closure treatment for left atrial appendage LLA with occluder, using a minimally invasive procedure treatment of structural heart disease

Related Content

Final Follow-Up Data Support Boston Scientific’s Watchman Stroke-Prevention Device

Dec 20 2019

Boston Scientific Expects Up To $40M Impact In Q1 From Coronavirus Outbreak; 10%-12% Revenue Increase For 2020

Feb 05 2020

Related Companies

Boston Scientific Corporation

Additional Topics

Clinical Trials Innovation Research & Development Cardiovascular Medical Device

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About

About UsOpens in new window
Meet the Team
AdvertiseOpens in new window
Contact Us

Account

My Account
My View
Email Preferences
Start Free TrialOpens in new window

More

Medtech Top 100 Ranking
Data Trackers
FDA Warning Letters

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window